Advanced

Insights into cancer surveillance in Central and Eastern Europe, Israel and Turkey

Vrdoljak, E.; Torday, L.; Sella, A.; Leyman, S.; Bavbek, S.; Kharkevich, G.; Mardiak, J.; Szczylik, C.; Znaor, A. and Wilking, Nils LU (2015) In European Journal of Cancer Care 24(1). p.99-110
Abstract
The current cancer landscape within transitional economies in central and Eastern Europe and the Mediterranean area is not particularly optimistic. Current perceptions are often based on extrapolations from other countries and regions; and hence the authors collaborated with the South Eastern Europe Oncology Group (SEEROG) to collect information on cancer registration in Central and Eastern Europe, Israel and Turkey. Healthcare authorities and specialist oncology centres in 21 countries in the region were contacted for information on cancer registries in their countries. Based on this information, the authors believe that the recording and reporting of data on cancer in the region is at an acceptable level. The authors discuss and compare... (More)
The current cancer landscape within transitional economies in central and Eastern Europe and the Mediterranean area is not particularly optimistic. Current perceptions are often based on extrapolations from other countries and regions; and hence the authors collaborated with the South Eastern Europe Oncology Group (SEEROG) to collect information on cancer registration in Central and Eastern Europe, Israel and Turkey. Healthcare authorities and specialist oncology centres in 21 countries in the region were contacted for information on cancer registries in their countries. Based on this information, the authors believe that the recording and reporting of data on cancer in the region is at an acceptable level. The authors discuss and compare institution- and population-based registries, and present opinions on elements of an ideal registry' based on the survey replies and comparisons with other registries. A comparison with the sources used for GLOBOCAN 2008 illustrates the need for consistent data to be communicated, published and utilised throughout the region and the oncology community. The authors conclude by considering the potential value of collaboration between health authorities across the region, as well as between the clinical and epidemiological communities, to ensure that cancer data are consistently collected, verified and made public. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
cancer epidemiology, Central and Eastern Europe, Israel, Turkey, population-based cancer registries, institution-based registries
in
European Journal of Cancer Care
volume
24
issue
1
pages
99 - 110
publisher
John Wiley & Sons
external identifiers
  • wos:000346768500010
  • scopus:84919860782
ISSN
1365-2354
DOI
10.1111/ecc.12149
language
English
LU publication?
yes
id
843ee60d-0c1e-40f5-ad92-0a0f51c7c4d0 (old id 4941318)
date added to LUP
2015-02-03 07:17:03
date last changed
2017-04-02 03:02:16
@article{843ee60d-0c1e-40f5-ad92-0a0f51c7c4d0,
  abstract     = {The current cancer landscape within transitional economies in central and Eastern Europe and the Mediterranean area is not particularly optimistic. Current perceptions are often based on extrapolations from other countries and regions; and hence the authors collaborated with the South Eastern Europe Oncology Group (SEEROG) to collect information on cancer registration in Central and Eastern Europe, Israel and Turkey. Healthcare authorities and specialist oncology centres in 21 countries in the region were contacted for information on cancer registries in their countries. Based on this information, the authors believe that the recording and reporting of data on cancer in the region is at an acceptable level. The authors discuss and compare institution- and population-based registries, and present opinions on elements of an ideal registry' based on the survey replies and comparisons with other registries. A comparison with the sources used for GLOBOCAN 2008 illustrates the need for consistent data to be communicated, published and utilised throughout the region and the oncology community. The authors conclude by considering the potential value of collaboration between health authorities across the region, as well as between the clinical and epidemiological communities, to ensure that cancer data are consistently collected, verified and made public.},
  author       = {Vrdoljak, E. and Torday, L. and Sella, A. and Leyman, S. and Bavbek, S. and Kharkevich, G. and Mardiak, J. and Szczylik, C. and Znaor, A. and Wilking, Nils},
  issn         = {1365-2354},
  keyword      = {cancer epidemiology,Central and Eastern Europe,Israel,Turkey,population-based cancer registries,institution-based registries},
  language     = {eng},
  number       = {1},
  pages        = {99--110},
  publisher    = {John Wiley & Sons},
  series       = {European Journal of Cancer Care},
  title        = {Insights into cancer surveillance in Central and Eastern Europe, Israel and Turkey},
  url          = {http://dx.doi.org/10.1111/ecc.12149},
  volume       = {24},
  year         = {2015},
}